THE RELATIONSHIP BETWEEN SALIVARY PEPSIN CONCENTRATION AND LOWER ESOPHAGEAL SPHINCTER IN PATIENT WITH GASTROESOPHAGEAL REFLUX SYMPTOMS

Thuỳ Linh Nguyễn, Đình Tùng Lê, Văn Long Đào, Việt Hằng Đào

Main Article Content

Abstract

Aim: To describe pepsin in saliva by using Peptest and evaluate the relation between pepsin concentrations and lower esophageal sphincter (LES) in patients with gastroesophageal reflux symptoms. Method: A cross-sectional study was conducted in patients with gastroesophageal reflux symptoms at Institute of Gastroenterology and Hepatology from 06/2020 to 03/2023. Pepsin in saliva was detected by Peptest while LES was detected by high – resolution manometry (HRM). Results: 141 patients with average age of 43,1 ± 11,7, male percentage was 42,6%. Regurgitation was the most frequent symptom. The positive rate of Peptest was 89,9% in sample 1 (pepsin concentration was 79,1 ng/ml) and 81,8% in sample 2 (pepsin concentration was 62,6 ng/ml). There was no significant different in pepsin concentration between LES resting pressure baseline/swallow low/normal, IRP4s low/normal, EGJ-CI low/normal, EGJ morphology and IRP4s combined with esophageal motility low/normal (p < 0,05). There was a slight correlation between LES resting pressure when swallowing, IRP4s with pepsin concentrations. Conclusion: The rate of positive Peptest samples and pepsin concentration in saliva in patients with gastroesophageal reflux symptoms were high. There was a weak correlation between LES resting pressure when swallowing or IRP4s, but no correlation between the LES resting pressure baseline or EGJ – CI with the concentration of pepsin in saliva.

Article Details

References

1. El-Serag HB. Epidemiology of Non-Erosive Reflux Disease. Digestion. 2008;78(1):6-10. doi:10.1159/000151249
2. Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Official journal of the American College of Gastroenterology | ACG. 2022;117(1):27. doi:10. 14309/ajg.0000000000001538
3. The Chicago Classification of Esophageal Motility Disorders, v3.0. Neurogastroenterol Motil. 2015;27(2): 160-174. doi: 10.1111/ nmo.12477
4. Nicodème F, Pipa‐Muniz M, Khanna K, Kahrilas PJ, Pandolfino JE. Quantifying esophagogastric junction contractility with a novel HRM topographic metric, the EGJ ‐Contractile Integral: normative values and preliminary evaluation in PPI non‐responders. Neurogastroenterology Motil. 2014;26(3):353-360. doi:10.1111/nmo.12267
5. Wang YJ, Lang XQ, Wu D, et al. Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders. J Neurogastroenterol Motil. 2020; 26(1):74-84. doi:10.5056/jnm19032
6. Bor S, Capanoglu D, Vardar R, Woodcock AD, Fisher J, Dettmar PW. Validation of PeptestTM in Patients with Gastro-Esophageal Reflux Disease and Laryngopharyngeal Reflux Undergoing Impedance Testing. Journal of Gastrointestinal and Liver Diseases. 2019;28(4): 383-387. doi:10.15403/jgld-335
7. Nguyen LT, Le TD, Hoang LB, et al. Threshold level of Peptest in diagnosing gastroesophageal reflux disease with extraesophageal symptoms: Evidence from Vietnam. JGH Open. 2023;7(12): 916-922. doi:10.1002/jgh3.13002
8. Guo Z, Wu Y, Li L, Chen J, Zhang S, Zhang C. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring. Med Sci Monit. 2020;26:e927381-1-e927381-9. doi:10.12659/MSM.927381